Met receptor inhibitor SU11274 localizes in the endoplasmic reticulum

Edwin J Wiest1, Heather Jensen Smith2, Michael A Hollingsworth1

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Eppley Institute, Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

Insights

SU11274, a c-Met inhibitor, fluoresces and accumulates in specific cell parts. This study found it primarily targets the endoplasmic reticulum in human pancreatic cancer cells.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • SU11274 is a known class I c-Met inhibitor with anti-cancer properties.
  • The drug exhibits unique fluorescent properties when exposed to 488 nm laser light.
  • Understanding drug localization is crucial for cancer therapy optimization.

Purpose of the Study:

  • To investigate the subcellular localization and accumulation patterns of SU11274.
  • To identify specific organelles targeted by SU11274 in human pancreatic cancer cells.
  • To leverage the fluorescent properties of SU11274 for intracellular tracking.

Main Methods:

  • Utilizing the intrinsic fluorescence of SU11274.
  • Employing laser excitation at 488 nm.
  • Microscopy techniques to observe intracellular distribution in pancreatic cancer cells.

Main Results:

  • SU11274 demonstrated rapid and specific accumulation within cells.
  • The drug's fluorescent properties facilitated visualization of its intracellular trafficking.
  • Predominant accumulation of SU11274 was observed in the endoplasmic reticulum.

Conclusions:

  • SU11274 is rapidly trafficked and predominantly accumulates in the endoplasmic reticulum.
  • The endoplasmic reticulum is a key organelle for SU11274 localization in pancreatic cancer.
  • These findings provide insights into the pharmacodynamics of SU11274.

Related Concept Videos

Endoplasmic Reticulum01:39

Endoplasmic Reticulum

The Endoplasmic Reticulum (ER) in eukaryotic cells is a substantial network of interconnected membranes with diverse functions, from calcium storage to biomolecule synthesis. A primary component of the endomembrane system, the ER manufactures phospholipids critical for membrane function throughout the cell. Additionally, the two distinct regions of the ER specialize in the manufacture of specific lipids and proteins.
110.5K
The Endoplasmic Reticulum01:43

The Endoplasmic Reticulum

The endoplasmic reticulum or ER makes up for more than half of the membranes in a cell and accounts for 10% of total cell volume. It is also the primary protein and lipid synthesis factory for most cell organelles, such as the Golgi apparatus, lysosomes, secretory vesicles, and the plasma membrane. Despite being the most extensive and functionally complex subcellular organelle, ER was the last to be discovered. After years of deliberation, Keith Porter and George Palade in the year 1954,...
21.7K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
8.2K
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
17.8K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
656
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K